Catalyst Pharmaceuticals Inc (CPRX)

Quick ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cash US$ in thousands 137,636 120,971 178,787 148,247 298,395 256,065 210,912 178,372 171,445 154,836 135,295 127,328 130,237 117,106 115,052 101,751 89,512 44,983 23,418 19,082
Short-term investments US$ in thousands 0 0 — — 0 0 9,876 19,424 19,821 19,956 19,980 15,971 10,041 10,003 0 5,007 5,007 31,562 36,503 26,551
Receivables US$ in thousands 53,514 48,049 42,796 33,402 10,439 9,337 9,587 10,552 6,619 6,625 6,292 5,601 5,987 5,872 6,762 6,919 10,537 10,095 10,376 7,251
Total current liabilities US$ in thousands 76,063 57,806 52,503 56,709 57,588 44,681 22,488 22,938 27,063 20,614 16,135 14,436 22,756 18,232 20,210 17,636 24,099 17,982 14,152 9,026
Quick ratio 2.51 2.92 4.22 3.20 5.36 5.94 10.24 9.08 7.31 8.80 10.01 10.31 6.43 7.29 6.03 6.45 4.36 4.82 4.97 5.86

December 31, 2023 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($137,636K + $0K + $53,514K) ÷ $76,063K
= 2.51

The quick ratio of Catalyst Pharmaceuticals Inc has shown fluctuations over the past several quarters. The quick ratio measures the company's ability to meet its short-term obligations with its most liquid assets, excluding inventory.

From the data provided, we observe that the quick ratio has generally been above 1, indicating that the company has had an adequate level of liquid assets to cover its current liabilities. The quick ratio has ranged from a high of 10.31 in March 2021 to a low of 2.51 in December 2023.

The trend in the quick ratio shows that Catalyst Pharmaceuticals Inc has maintained a strong liquidity position over the periods analyzed. A high quick ratio suggests that the company has a low level of risk of facing liquidity issues in the near term, as it has a significant amount of liquid assets relative to its current liabilities.

Overall, the quick ratio analysis indicates that Catalyst Pharmaceuticals Inc has had a consistent ability to meet its short-term obligations with its readily available assets, providing a positive signal regarding its financial health. However, it is important to monitor the trend of the quick ratio over time to ensure that the company's liquidity position remains stable and sustainable.